Benzinga

JANUARY 16, 2024

cannabis regulation, Lance Boldrey , leader of Cannabis Law Practice at Dykema Gossett PLLC , analyzes the potential impact of reclassifying cannabis to Schedule III under the Controlled Substance Act. “As a Schedule III controlled substance, cannabis could be sold as medicine. Amidst potential shifts in U.S.

Marketability 69

Marketability 69

Benzinga

JULY 22, 2022

Vertical integration in the cannabis industry is one of the most debated topics of the day across the sector. As part of America's piecemeal approach to state-level legalization, states can choose their regulations. Not so cut-and-dried to most, the business model offers numerous benefits and drawbacks.

Marketability 98

Marketability 98

Appraisal Rights

MAY 5, 2021

RKS is covering the the Cannalaw Summit, a conference covering a range of topics including cannabis valuation. Beyond the newest US states to legalize recreational cannabis use, Mexico is proceeding with legalization steps in what observers said could become “the world’s largest cannabis market.”

Marketability 40

Marketability 40

Reynolds Holding

OCTOBER 5, 2022

On the other hand, cybersecurity filings, along with opioid and cannabis cases, are on pace to decrease significantly. Aspects of the decision in Goldstein suggest this is a topic that the court may be interested in exploring more in the future. Summary of Trend Cases—Core Federal Filings 2018 – June 2022. . at *2–3, *46, *50.

Start-ups 72

Start-ups Marketability Equity Compliance 72